Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Colorectal medullary carcinoma: a pathological subtype with intense immune response and potential to benefit from immune checkpoint inhibitors.

Expert review of clinical immunology - 1 Aug 2024

Zou Haoyi, Liu Chao, Ruan Yuli, Fang Lin, Wu Tong, Han Shuling, Dang Tianjiao, Meng Hongxue, Zhang Yanqiao

Abstract excerpt

INTRODUCTION: Different pathological types of colorectal cancer have distinguished immune landscape, and the efficacy of immunotherapy will be completely different. Colorectal medullary carcinoma, accounting for 2.2-3.2%, is characterized by massive lymphocyte infiltration. However, the attention to the immune characteristics of colorectal medullary carcinoma is insufficient. AREA COVERED: We searched the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B7-H1 Antigen
Share to Carcinoma, Medullary

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colorectal Neoplasms

Share to Immune Checkpoint Inhibitors

Share to Immunotherapy

Share to Lymphocytes, Tumor-Infiltrating

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Source

Identifiers

PMID: 38459764
DOI: 10.1080/1744666X.2024.2328746

Genes

BRAF
ARID1A

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Colorectal medullary carcinoma: a pathological subtype with intense immune response and potential to benefit from immune checkpoint inhibitors.PMID 38459764Read ↗

Immune Landscape Refines the Classification of Colorectal Cancer With Heterogeneous Prognosis, Tumor Microenvironment and Distinct Sensitivity to Frontline TherapiesSemantic proximity Read ↗

Unraveling Resistance to Immunotherapy in MSI-High Colorectal CancerSemantic proximity Read ↗

The next bastion to be conquered in immunotherapy: microsatellite stable colorectal cancerSemantic proximity Read ↗

Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside.Semantic proximity Read ↗

The clinical implications of immunogenomics in colorectal cancer: A path for precision medicineSemantic proximity Read ↗

Comprehensive characterization of tumor microenvironment in colorectal cancer via histopathology-molecular analysisSemantic proximity Read ↗

Immunogenomic Classification of Colorectal Cancer and Therapeutic ImplicationsSemantic proximity Read ↗

Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistanceSemantic proximity Read ↗

Medullary carcinoma in the colorectum: a systematic review and meta-analysis.Semantic proximity Read ↗

An update on colorectal cancer microenvironment, epigenetic and immunotherapy.Semantic proximity Read ↗

Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistanceSemantic proximity Read ↗

The ratio of cytotoxic lymphocytes to M2-like macrophages is prognostic in immunogenic tumorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.